© 2018 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Cure

Experimental Agent Shrinks HIV Reservoir, but Fails to Delay Viral Rebound
#Prevention
#PrEP

Your Opinion Matters!

Take a survey on HIV cure research.
David Wohl, MD, of University of North Carolina School of Medicine

This New Podcast Explores Living a Long Life With HIV

It’s just one episode of “HIV Matters,” a (free!) podcast series from the University of North Carolina’s Department of Medicine.

“Shock and Kill” HIV Cure Method May Be Too Anemic to Work

A recent study found that agents used to wake up resting HIV-infected cells probably work only on 5 percent of such cells.

Cure: Delaying Rebound

Scientists tested the effects of the broadly neutralizing antibody PGT121 and the immune-stimulating agent GS-9620 in monkeys.

Crystal Meth May Lead Even Well-Treated HIV to Further Harm the Body

According to a pair of recent studies, meth was associated with certain HIV-related genetic and immune changes.

Gene-Editing Study in Monkeys Sets Stage for Further HIV Cure Research

Scientists succeeded in editing the animals’ stem cells to resist an HIV-like virus and ultimately shrink their viral reservoir.

MUST read

bright sun shining in blue sky with white clouds
#Long-Term Survivors
#Life Expectancy
#Newly Diagnosed
A CD4 cell

Molecule Thought to Indicate HIV Reservoir Actually Does Not

Researchers say CD32 is not a biomarker for immune cells latently infected with HIV but one for actively infected cells.

The Role of Vaccines and Cures in HIV Elimination

An update from the director of the Basic Science, Vaccines and Cure Project at Treatment Action Group (TAG).

Is Curing Patients Good for Business? Asks Goldman Sachs Biotech Report

For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.

Cure: CAR-T Cells

Research shows that CAR-T cells could one day help cure HIV in humans.
The opening session of CROI 2018 in Boston.

The Best of CROI 2018

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Hot topics

HIV: The Basics
Ask POZ
The National Cancer Institute’s Mary Kearney, PhD, speaks at CROI 2018 in Boston.

Scientists Find No Signs That Well-Treated HIV Replicates in Lymph Nodes

This finding stands in sharp contrast to a controversial 2016 paper that reached the opposite conclusion.

Pair of Agents Delays Viral Rebound in Primates Infected With Simian HIV

Scientists tested the effects of the broadly neutralizing antibody PGT121 and the immune-stimulating agent GS-9620 in monkeys.

“Towards an HIV Cure” Initiative Has Two New Leaders

Sharon Lewin and Mark Dybul replace Jack Whitescarver and Françoise Barré-Sinoussi as cochairs of the advisory board.

Cure: Mouse Study

The researchers studied a new compound that blocked a key viral protein that prompts infected cells to produce more virus.
A CD4 cell

Levels of CD4 Cells With Gut-Homing Protein Are Linked to HIV Risk

Researchers discovered that higher levels of such cells were tied not only to infection risk but also HIV disease progression.
Advertisement
Newsfeed
Treatment News
Features
Opinions